Your browser doesn't support javascript.
loading
Efficacy after 1 and 2 doses of CYD-TDV in dengue endemic areas by dengue serostatus.
Dayan, Gustavo H; Langevin, Edith; Forrat, Remi; Zambrano, Betzana; Noriega, Fernando; Frago, Carina; Bouckenooghe, Alain; Machabert, Tifany; Savarino, Stephen; DiazGranados, Carlos A.
  • Dayan GH; Sanofi Pasteur, Swiftwater, PA, USA. Electronic address: Gustavo.Dayan@sanofi.com.
  • Langevin E; Sanofi Pasteur, Marcy L'Étoile, France. Electronic address: Edith.Langevin@sanofi.com.
  • Forrat R; Sanofi Pasteur, Marcy L'Étoile, France. Electronic address: Remi.Forrat@sanofi.com.
  • Zambrano B; Sanofi Pasteur, Montevideo, Uruguay. Electronic address: Betzana.Zambrano@sanofi.com.
  • Noriega F; Sanofi Pasteur, Swiftwater, PA, USA. Electronic address: Fernando.Noriega@sanofi.com.
  • Frago C; Sanofi Pasteur, Singapore, Singapore. Electronic address: Carina.Frago@sanofi.com.
  • Bouckenooghe A; Sanofi Pasteur, Singapore, Singapore.
  • Machabert T; Sanofi Pasteur, Marcy L'Étoile, France. Electronic address: Tifany.Machabert@sanofi.com.
  • Savarino S; Sanofi Pasteur, Swiftwater, PA, USA. Electronic address: Stephen.Savarino@sanofi.com.
  • DiazGranados CA; Sanofi Pasteur, Marcy L'Étoile, France. Electronic address: Carlos.DiazGranados@sanofi.com.
Vaccine ; 38(41): 6472-6477, 2020 09 22.
Article en En | MEDLINE | ID: mdl-32773243

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Dengue / Virus del Dengue / Vacunas contra el Dengue Límite: Aged / Humans Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Dengue / Virus del Dengue / Vacunas contra el Dengue Límite: Aged / Humans Idioma: En Año: 2020 Tipo del documento: Article